drugset / Trial / NCT00632814
Russian Kogenate Pediatric Study
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A prospective study to evaluate the effect of rFVIII-FS in different prophylactic regimens on bleeding events frequency and development of arthropathy in Previously Treated and Minimally treated Hemophilia A pediatric population.
Timeline
- Start
- 2007-06
- Primary completion
- 2009-09
- Completion
- 2009-09
Publications
- Results V.V. Vdovin, T.A. Andreeva, T.A. Chernova, F.G. Perina, E.E.M. Shiller, P.V. Svirin, M. Maas Enriquez, and S. Rauchensteiner. Prophylaxis with Once, Twice or Three-Times Weekly Dosing of rFVIII-FS Prevents Joint Bleeds in a Previously Treated Pediatric Population with Moderate/Severe Hemophilia A. Journal of Coagulation Disorders 2011; 3:(1). October 2011
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADVATE | Protein / enzyme biologic | 70 iu/kg | Other |
| Subject | ADVATE | Protein / enzyme biologic | 75 iu/kg | Other |